Results Presented at American Society for Hematology
WILMINGTON, DE ? December 10, 2001 ? Interim results of a Phase II trial comparing AstraZeneca's investigational oral direct thrombin inhibitor EXANTA (ximelagatran) to warfarin for the prevention of strokes in patients with chronic...